Memantine: a new approach to Alzheimer's disease.
Keltner
Norman L
NL
University of Alabama at Birmingham, USA. KELTNERN@son.uab.edu
Williams
Beth
B
D000544:Alzheimer Disease / Q000188:drug therapy / Q000451:nursing*; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D018691:Excitatory Amino Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008559:Memantine / Q000009:adverse effects / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
D018691:Excitatory Amino Acid Antagonists; D018697:Nootropic Agents; D016194:Receptors, N-Methyl-D-Aspartate; D008559:Memantine